Ureterolithiasis disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: URT014 MIFTS: 39	Ureterolithiasis Categories: Nephrological diseases
Genes Tissues Related diseases Publications Pathways Drugs Expand all tables

Sources

Aliases & Classifications for Ureterolithiasis

MalaCards integrated aliases for Ureterolithiasis:

Name: Ureterolithiasis ¹² ⁴⁵ ¹⁵ ¹⁷ ⁷⁴

Calculus of Ureter ¹²

Ureteric Calculus ¹²

Ureteral Calculi ⁷⁴

Ureteric Stone ¹²

Classifications:

MalaCards categories:
Anatomical: Nephrological diseases

See all MalaCards categories (disease lists)

ICD10: ³⁴

Diseases of the genitourinary system

Urolithiasis

Calculus of kidney and ureter

Calculus of ureter

External Ids:

Disease Ontology ¹² DOID:14146

ICD9CM ³⁶ 592.1

MeSH ⁴⁵ D053039

NCIt ⁵¹ C114696

SNOMED-CT ⁶⁹ 31054009 95573009

ICD10 ³⁴ N20.1

EFO ¹⁷ EFO_1001228

UMLS ⁷⁴ C0041952 C1456865

Sources

Summaries for Ureterolithiasis

MalaCards based summary : Ureterolithiasis, also known as calculus of ureter, is related to nephrolithiasis and nephrolithiasis, calcium oxalate. An important gene associated with Ureterolithiasis is APRT (Adenine Phosphoribosyltransferase), and among its related pathways/superpathways are Calcium signaling pathway and Salivary secretion. The drugs Tamsulosin and Alfuzosin have been mentioned in the context of this disorder. Affiliated tissues include kidney and adrenal gland, and related phenotypes are behavior/neurological and renal/urinary system

Wikipedia : ⁷⁷ Kidney stone disease, also known as urolithiasis, is when a solid piece of material (kidney stone)... more...

Sources

Related Diseases for Ureterolithiasis

Diseases related to Ureterolithiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 48)

#	Related Disease	Score
1	nephrolithiasis	10.5
2	nephrolithiasis, calcium oxalate	10.3
3	appendicitis	10.2
4	horns in sheep	10.2
5	hydronephrosis	10.1
6	urinary tract obstruction	10.1
7	ureterocele	10.0
8	cystinuria	10.0
9	adenine phosphoribosyltransferase deficiency	10.0
10	atrial fibrillation	10.0
11	pyelonephritis	10.0
12	squamous cell papilloma	10.0
13	papilloma	10.0
14	endometriosis	10.0
15	anuria	10.0
16	ureteral obstruction	10.0
17	dihydroxyadeninuria	10.0
18	renal dysplasia	10.0
19	exstrophy of bladder	9.9
20	ureteral benign neoplasm	9.9
21	transitional cell carcinoma	9.9
22	angiomyolipoma	9.9
23	embryoma	9.9
24	priapism	9.9
25	meningitis	9.9
26	tuberculous meningitis	9.9
27	fibromuscular dysplasia	9.9
28	thrombocytopenic purpura, autoimmune	9.9
29	vesicoureteral reflux 1	9.9
30	brittle bone disorder	9.9
31	end stage renal failure	9.9
32	morbid obesity	9.9
33	systemic mastocytosis	9.9
34	small cell carcinoma	9.9
35	thrombosis	9.9
36	azoospermia	9.9
37	cystitis	9.9
38	ankylosis	9.9
39	gastroenteritis	9.9
40	glandular cystitis	9.9
41	teratoma	9.9
42	purpura	9.9
43	mastocytosis	9.9
44	uremia	9.9
45	acute pyelonephritis	9.9
46	adenoma	9.9
47	nephrogenic adenoma	9.9
48	actinomycosis	9.9

Comorbidity relations with Ureterolithiasis via Phenotypic Disease Network (PDN): (show all 12)

Acute Cystitis	Bladder Neck Obstruction
Hydronephrosis	Nephrolithiasis, Uric Acid
Nephrolithiasis, X-Linked Recessive, with Renal Failure	Paralytic Ileus
Prostate Cancer	Prostatic Hypertrophy
Pyelonephritis	Urethral Calculus
Urethral Stricture	Urinary Tract Obstruction

Graphical network of the top 20 diseases related to Ureterolithiasis:

Sources

Symptoms & Phenotypes for Ureterolithiasis

MGI Mouse Phenotypes related to Ureterolithiasis:

⁴⁷

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	behavior/neurological	MP:0005386	9.35	ADRA1A AKAP5 APBB1 APRT CHRM3
2	renal/urinary system	MP:0005367	8.92	ADRA1A APRT CHRM3 SLC12A3

Sources

Drugs & Therapeutics for Ureterolithiasis

Drugs for Ureterolithiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 95)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Tamsulosin

Approved, Investigational

Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1

106133-20-4

129211

Alfuzosin

Approved, Investigational

Phase 4,Phase 3,Phase 2,Not Applicable

81403-80-7

2092

Nefopam

Approved, Investigational

Phase 4

13669-70-0

Morphine

Approved, Investigational

Phase 4

57-27-2

5288826

Ketorolac

Approved

Phase 4

66635-83-4, 74103-06-3

3826

Diclofenac

Approved, Vet_approved

Phase 4,Not Applicable

15307-86-5

3033

Ketoprofen

Approved, Vet_approved

Phase 4

22071-15-4

3825

Silodosin

Approved

Phase 4,Phase 3,Phase 2

160970-54-7

Acetaminophen

Approved

Phase 4,Phase 3,Not Applicable

103-90-2

1983

Oxycodone

Approved, Illicit, Investigational

Phase 4,Not Applicable

76-42-6

5284603

Ciprofloxacin

Approved, Investigational

Phase 4

85721-33-1

2764

Sodium Citrate

Approved, Investigational

Phase 4

68-04-2

Tadalafil

Approved, Investigational

Phase 4

171596-29-5

110635

Calcium

Approved, Nutraceutical

Phase 4,Phase 3

7440-70-2

271

Citric Acid

Approved, Nutraceutical, Vet_approved

Phase 4

77-92-9

311

Naftopidil

Investigational

Phase 4,Phase 3

57149-07-2

Adrenergic Antagonists

Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1

Adrenergic alpha-1 Receptor Antagonists

Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1

Neurotransmitter Agents

Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1

Adrenergic alpha-Antagonists

Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1

Adrenergic Agents

Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1

Hormones

Phase 4,Phase 3,Not Applicable

calcium channel blockers

Phase 4,Phase 3

Calcium, Dietary

Phase 4,Phase 3

Antihypertensive Agents

Phase 4,Phase 3

Platelet Aggregation Inhibitors

Phase 4,Phase 3

Analgesics, Non-Narcotic

Phase 4,Not Applicable

Antirheumatic Agents

Phase 4,Not Applicable

Analgesics

Phase 4,Phase 3,Not Applicable

Anti-Inflammatory Agents, Non-Steroidal

Phase 4,Not Applicable

Narcotics

Phase 4,Not Applicable

Cyclooxygenase Inhibitors

Phase 4,Not Applicable

Ketorolac Tromethamine

Phase 4

Central Nervous System Depressants

Phase 4,Not Applicable

Peripheral Nervous System Agents

Phase 4,Phase 3,Not Applicable

Analgesics, Opioid

Phase 4,Not Applicable

Anti-Inflammatory Agents

Phase 4,Not Applicable

Vasodilator Agents

Phase 4,Phase 3

Pharmaceutical Solutions

Phase 4,Not Applicable

Antipyretics

Phase 4,Not Applicable

Anti-Bacterial Agents

Phase 4,Not Applicable

Anti-Infective Agents

Phase 4,Not Applicable

Antibiotics, Antitubercular

Phase 4,Not Applicable

Cytochrome P-450 Enzyme Inhibitors

Phase 4

Cytochrome P-450 CYP1A2 Inhibitors

Phase 4

Topoisomerase Inhibitors

Phase 4

Cyclooxygenase 2 Inhibitors

Phase 4,Not Applicable

Phosphodiesterase Inhibitors

Phase 4

Phosphodiesterase 5 Inhibitors

Phase 4

Citrate

Phase 4

Interventional clinical trials:

(show top 50) (show all 83)

#	Name	Status	NCT ID	Phase	Drugs
1	Treatment of Upper Ureteric Stones	Unknown status	NCT02469766	Phase 4
2	The Use of Medical-Expulsive Therapy With Alfuzocine xl 10mg x1/d for Distal Ureterolithiasis.a Randomized Prospective Study	Unknown status	NCT00489112	Phase 4	Alfuzocine XL 10 mg once a day
3	Efficacy of Tamsulosin Oral-controlled Absorption System (OCAS) in the Treatment of Distal Ureteral Stones	Unknown status	NCT01167062	Phase 4	Tamsulosin Hydrochloride OCAS 0.4 mg
4	The Efficacy of Alpha-blockers for Expulsion of Distal Ureteral Stones	Unknown status	NCT00451061	Phase 4	Alfuzosin;Tamsulosin
5	Naftopidil 75mg for Improving Clearance of Urinary Stones	Unknown status	NCT02011737	Phase 4	naftopidil 75mg
6	Efficacy of Nefopam and Morphine in Balanced Analgesia for Acute Ureteric Colic	Unknown status	NCT01543165	Phase 4	Ketorolac and nefopam balanced analgesia;Balanced analgesia using ketorolac and morphine;Pain control with single analgesics (ketorolac)
7	Nefopam and Morphine Consumption in the Treatment of Ureteral Calculi	Completed	NCT00639574	Phase 4	Néfopam
8	Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones	Completed	NCT01533389	Phase 4	Silodosin;Placebo
9	Tamsulosin for Urolithiasis in the Emergency Dept	Completed	NCT00382265	Phase 4	tamsulosin
10	Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management	Completed	NCT02187614	Phase 4	Diclofenac;Morphine;Paracetamol;Placebos
11	Antibiotic Prophylaxis Before Shock Wave Lithotripsy	Recruiting	NCT03692715	Phase 4	Ciprofloxacin;Placebo
12	Tamsulosin as Adjuvant Treatment Prior to Endoscopic Ureterolithotomy	Recruiting	NCT03614052	Phase 4	Tamsulosin Hydrochloride 0.4 MG;Placebo Oral Tablet
13	Study of Ketorolac Versus Opioid for Pain After Endoscopy	Recruiting	NCT03888144	Phase 4	Oxycodone;Ketorolac
14	Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) as Medical Expulsive Therapy in Distal Ureteral Stones	Active, not recruiting	NCT02519153	Phase 4	Sildenafil
15	Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment	Enrolling by invitation	NCT03229889	Phase 4	Cialis 5Mg Tablet;Flomax 0.4Mg Capsule;Placebo
16	Silodosin Versus Tamsulosin for Treatment of Ureteral Stones	Terminated	NCT02369744	Phase 4	Silodosin;Tamsulosin
17	Celecoxib (Celebrex) in the Management of Acute Renal Colic	Withdrawn	NCT00304317	Phase 4	celecoxib
18	Alfuzosin for Medical Expulsion Therapy of Ureteral Stones	Unknown status	NCT00713739	Phase 3	Alfuzosin;nifedipine;doxazosin;prazosin
19	Evaluation of Tamsulosin in the Treatment of Ureteral Stones	Completed	NCT00151567	Phase 3	Tamsulosin;Placebo
20	Medical Expulsive Therapy for Ureter Stone Using Naftopidil	Completed	NCT01952314	Phase 3	Naftopidil 75mg;Placebo for Naftopidil;Standard treatment
21	Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi	Completed	NCT00177086	Phase 3
22	Effectiveness of Silodosin in Medical Expulsive Therapy for Ureteral Pelvic Stone From 4 to 10 mm.	Terminated	NCT02090439	Phase 3	Silodosin
23	Use of Alfuzosin in Stone Treatment With ESWL	Withdrawn	NCT00388271	Phase 3	Alfuzosin (Xatral);standard treatment
24	Comparing Patients After ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin	Unknown status	NCT00478998	Phase 2	Tamsulosin
25	Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy	Unknown status	NCT00409227	Phase 2	Alpha blocker-alfuzosin;placebo
26	Study of Silodosin to Facilitate Passage of Urinary Stones	Completed	NCT01144949	Phase 2	silodosin;placebo
27	A Dose-finding Study of Silodosin in Patients With Urinary Calculi	Completed	NCT01539265	Phase 2	silodosin;silodosin;placebo
28	Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain	Recruiting	NCT02744430	Phase 2	Mirabegron
29	Feasibility Study of the Uriprene Stent Following Uncomplicated Ureteroscopy	Completed	NCT02032316	Phase 1
30	Sterile Water Injections for Relieving Ureterolithiasis Pain	Unknown status	NCT01412840	Not Applicable
31	Silent Ureteral Stone: Impact on Renal Function and Kidney Anatomy	Unknown status	NCT01884870	Not Applicable
32	US-Non Contrast Computed Tomography Real-time Fusion for Urinary Stones Follow up	Unknown status	NCT02539004
33	Comparative Treatment Study in Patients With Lower Ureteral Stones	Unknown status	NCT00397397
34	Impact of Low Dose Fluoroscopy in Ureteroscopy	Unknown status	NCT02704949	Not Applicable
35	Shockwave Lithotripsy (SWL) Under Selective, General Anesthesia.	Unknown status	NCT01008267
36	Prospective Comparison Between Different Laser Settings for Ureteral \ Kidney Stones Treatment During Ureteroscopy	Unknown status	NCT02279927	Not Applicable
37	Intraureteral Lidocaine for Post-Ureteroscopy Pain	Unknown status	NCT01450566	Not Applicable	Lidocaine;Saline
38	Delayed or Direct Ureteroscopy in the Treatment of Pediatric Calcular Anuria	Unknown status	NCT02139059	Not Applicable
39	ESWL vs URS in Management of Upper Third Ureteric Calculi	Completed	NCT03559738
40	Comparing Uretersocopy With Versus Without Use of Guide-wire in Treatment of Ureteral Stone	Completed	NCT03726502	Not Applicable
41	The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients	Completed	NCT00600405	Not Applicable	tamsulosin;Standard therapy with ibuprofen and oxycodone.
42	Study on 'The Use of Non-contrast Helical Computerized Tomogram in Predicting Treatment Outcomes of Upper Ureteric Stone by Extracorporeal Shock Wave Lithotripsy Using the Sonolith 4000+ Lithotripter'	Completed	NCT00517205
43	Medical Expulsive Therapy of Single Distal Ureteral Stones	Completed	NCT00831701	Not Applicable	Tamsulosin;Placebo
44	The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients	Completed	NCT00448123	Not Applicable	Tamsulosin;Placebo
45	Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach	Completed	NCT01792765	Not Applicable
46	Effect of Tamsulosin on Stone Expulsion and Pain Resolution in ED Patients With Ureterolithiasis	Completed	NCT00762424	Not Applicable	Flowmax;placebo
47	Is Prophylactic Antibiotics Necessary In Otherwise Healthy Adult Patients Undergoing Ureteroscopic Procedures for Ureteral Stones?	Completed	NCT02635490
48	Use of the PercSys MicroStent Device to Alleviate Ureteral Stone Symptoms and Hydronephrosis	Completed	NCT01637519
49	Ureteral Stents Versus Percutaneous Nephrostomy for Initial Urinary Drainage	Completed	NCT02055430	Not Applicable
50	Role of Flexible Cystoscopy in Laparoscopic Stone Surgery	Completed	NCT01277198

Search NIH Clinical Center for Ureterolithiasis

Cochrane evidence based reviews: ureterolithiasis

Sources

Genetic Tests for Ureterolithiasis

Sources

Anatomical Context for Ureterolithiasis

MalaCards organs/tissues related to Ureterolithiasis:

⁴²

Kidney, Adrenal Gland

Sources

Publications for Ureterolithiasis

Articles related to Ureterolithiasis:

(show top 50) (show all 102)

#	Title	Authors	Year
1	Re: Minimizing the Cost of Treating Asymptomatic Ureterolithiasis. ( 30577359 )	Resnick MJ	2019
2	Bilateral ureterolithiasis: A true positive and false negative PoCUS exam in a patient with renal colic. ( 29606152 )	Lowe M.P....Cox C.	2018
3	Perinephric fat stranding is associated with elevated creatinine among patients with acutely obstructing ureterolithiasis. ( 29943669 )	Farrell M.R....Deane L.A.	2018
4	Acute synchronous appendicitis and obstructing ureterolithiasis. ( 30108673 )	Daniel SC...Khurana B	2018
5	Treatment of fungal pyelonephritis and ureterolithiasis with a subcutaneous ureteral bypass system and systemic antifungal medication in a cat. ( 30568915 )	McQuitty RG...Branter EM	2018
6	CONTACT ULTRASOUND LITHOTRIPSY DURING URETEROLITHIASIS THERAPY. AN ANALYSIS OF LATE POSTOPERATIVE COMPLICATIONS. ( 30358535 )	Stetsyshyn R...Danylchenko S	2018
7	Narcotic Pain Control for Ureterolithiasis Is Associated With Unnecessary Repeat Imaging in the Emergency Department. ( 30358635 )	Garcia K...Sharma P	2018
8	Epidemiological and imaging features that can affect the detection of ureterolithiasis on ultrasound. ( 30369654 )	Nery DR...Baroni RH	2018
9	Ureterolithiasis and the quest for rational use of diagnostic imaging methods. ( 30559568 )	Elias J	2018
10	Spontaneous proximal ureteric rupture secondary to ureterolithiasis. ( 28069871 )	Pace K....German K.	2017
11	Ureterolithiasis: Management in an environment with limited facilities. ( 28513524 )	Odoemene C.A....Ugonabo M.C.	2017
12	Comparison between double-pigtail ureteral stents and ureteral bypass devices for treatment of ureterolithiasis in cats. ( 28763282 )	Deroy C....Poncet C.	2017
13	Comparison of prone vs. supineA unenhanced CT imaging in patients with clinically suspected ureterolithiasis. ( 27670877 )	Meissnitzer M....Forstner R.	2016
14	Medical Expulsive Therapy for Ureterolithiasis: The EAU Recommendations in 2016. ( 27506951 )	TA1rk C....McClinton S.	2016
15	Beyond ureterolithiasis: gamut of abnormalities affecting the ureter. ( 27317212 )	Moosavi B....Kielar A.	2016
16	Is hydronephrosis on ultrasound predictive of ureterolithiasis in patients with renal colic? ( 27154825 )	Sternberg K.M....Eisner B.	2016
17	Management of Ureterolithiasis in a Patient with Crossed Unfused Renal Ectopia. ( 27403369 )	Kodama K....Tatsu H.	2016
18	Clinical relevance of seasonal changes in the prevalence of ureterolithiasis in the diagnosis of renal colic. ( 27314408 )	Fukuhara H....Tsuchiya N.	2016
19	Long-term Adverse Effects of Extracorporeal Shock-wave Lithotripsy for Nephrolithiasis and Ureterolithiasis: A Systematic Review. ( 25917723 )	Fankhauser C.D....Steurer J.	2015
20	The use of alpha-1 adrenergic blockers in children with distal ureterolithiasis: a systematic review and meta-analysis. ( 26717117 )	Glina F.P....Bernardo W.M.	2015
21	Tamsulosin for treatment of unilateral distal ureterolithiasis: a systematic review and meta-analysis. ( 24852587 )	Malo C....Turgeon A.F.	2014
22	Indwelling double pigtail ureteral stent combined or not with surgery for feline ureterolithiasis: complications and outcome in 15 cases. ( 24305471 )	Manassero M....Maurey C.	2013
23	Pyeloduodenal fistula due to proximal ureterolithiasis and its successful conservative management. ( 24051966 )	Fedorko M....NA9mcovA! E.	2013
24	Terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis. ( 23503876 )	Chua M.E....Morales M.L.	2013
25	Re: terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis. ( 23421365 )	Akin Y....Yucel S.	2013
26	Tamsulosin for treatment of unilateral distal ureterolithiasis: a systematic review and meta-analysis. ( 23870675 )	Malo C....Turgeon A.F.	2013
27	Anuria and abdominal pain induced by ceftriaxone-associated ureterolithiasis in adults. ( 23180444 )	Li Z.L....Chong T.	2013
28	Bladder bulge: unifying old and new sonographic bladder wall abnormalities in ureterolithiasis. ( 23358632 )	Bomann J.S....Rogers B.	2012
29	Bedside renal ultrasound in the evaluation of suspected ureterolithiasis. ( 21185667 )	Moak J.H....Lindsell C.J.	2012
30	Unusual presentation of bilateral ureteroceles with ureterolithiasis in a patient after robotic prostatectomy. ( 22546412 )	Lees T....Kella N.	2012
31	Synchronous obstructive ureterolithiasis and acute appendicitis. ( 24960802 )	Spiel A....Cowden W.	2012
32	Endoscopic holmium laser treatment for ureterolithiasis. ( 24578918 )	Purpurowicz Z....Sosnowski M.	2012
33	Health related quality of life in ureteral stone patients: post-ureterolithiasis. ( 21461963 )	Rabah D.M....Arafa M.A.	2011
34	Ureterolithiasis in children. ( 21585171 )	Jurkiewicz B....Samotyjek J.	2011
35	The effect of alpha-blockade in emergency department patients with ureterolithiasis. ( 19217243 )	Watts H.F....Kulstad E.B.	2010
36	The sensitivity of transabdominal ultrasound in the diagnosis of ureterolithiasis. ( 21203595 )	MoA9 C....HA8lbac M.	2010
37	A case of calcified ureteritis cystica: an indiscernible condition from ureterolithiasis. ( 19655701 )	Alicioglu B....Atakan I.H.	2009
38	Acute onset of renal colic from bilateral ureterolithiasis: a case report. ( 19829794 )	Miranda E.P....Scafuri A.G.	2009
39	Type IV ureteral triplication associated with ipsilateral ureterocele with ureterolithiasis and contralateral duplication with an ectopic ureteral orifice. ( 19138195 )	Park B.S.	2008
40	Conventional and reduced radiation dose of 16-MDCT for detection of nephrolithiasis and ureterolithiasis. ( 18094305 )	Paulson E.K....Frush D.P.	2008
41	Usefulness of urinalysis in following patients with distal ureterolithiasis. ( 18578655 )	Yoon G....Bellman G.	2008
42	The utility of unenhanced helical CT in assessing the frequency of ureterolithiasis in Saudi patients. ( 18246228 )	Al-Nakshabandi N.A....Al-Boukai A.A.	2008
43	Cost-effectiveness analysis (CEA) of intravenous urography (IVU) and unenhanced multidetector computed tomography (MDCT) for initial investigation of suspected acute ureterolithiasis. ( 18300151 )	Eikefjord E....rvik J.	2008
44	Comparison between ultrasound and noncontrast helical computed tomography for identification of acute ureterolithiasis in a teaching hospital setting. ( 17625708 )	de Souza L.R....Szejnfeld J.	2007
45	Ureteroscopical treatment of ureterolithiasis in childhood. Our experience. ( 16752883 )	Touloupidis S....Rombis V.	2006
46	Electro-acupuncture treatment for the upper segment ureterolithiasis under B-ultrasonography. ( 15889513 )	Lin Q....Leng J.	2005
47	Medical-expulsive therapy for distal ureterolithiasis: randomized prospective study on role of corticosteroids used in combination with tamsulosin-simplified treatment regimen and health-related quality of life. ( 16230122 )	Dellabella M....Muzzonigro G.	2005
48	Ureterolithiasis after Cohen re-implantation--case report. ( 15070415 )	Chaudhary S....Buchholz N.N.	2004
49	Diagnostic value of attenuation measurements of the kidney on unenhanced helical CT of obstructive ureterolithiasis. ( 15100127 )	Goldman S.M....Szejnfeld J.	2004
50	Unenhanced helical CT of ureterolithiasis: incidence of secondary urinary tract findings. ( 15058632 )	Yaqoob J....Mosharaf F.	2004

Sources

Genes for Ureterolithiasis

Genes related to Ureterolithiasis (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	APRT	Adenine Phosphoribosyltransferase	Protein Coding	16.91	GeneCards inferred via : Publications (show sections)
2	SLC12A3	Solute Carrier Family 12 Member 3	Protein Coding	16.64	DISEASES inferred ¹⁵
3	AKAP5	A-Kinase Anchoring Protein 5	Protein Coding	15.67	DISEASES inferred ¹⁵
4	APBB1	Amyloid Beta Precursor Protein Binding Family B Member 1	Protein Coding	14.8	DISEASES inferred ¹⁵
5	CHRM3	Cholinergic Receptor Muscarinic 3	Protein Coding	14.79	DISEASES inferred ¹⁵
6	ADRA1A	Adrenoceptor Alpha 1A	Protein Coding	14.79	DISEASES inferred ¹⁵

Sources

Variations for Ureterolithiasis

Sources

Expression for Ureterolithiasis

Search GEO for disease gene expression data for Ureterolithiasis.

Sources

Pathways for Ureterolithiasis

Pathways related to Ureterolithiasis according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	Calcium signaling pathway ³⁸	11.43	ADRA1A CHRM3
2	Salivary secretion ³⁸ Show member pathways Gastric acid secretion ³⁸	11.17	ADRA1A CHRM3
3	Monoamine GPCRs ¹ Show member pathways Adrenaline signalling through Alpha-2 adrenergic receptor ⁶⁷ Adrenoceptors ⁶⁷ Amine ligand-binding receptors ⁶⁷ Histamine receptors ⁶⁷ Muscarinic acetylcholine receptors ⁶⁷ Serotonin receptors ⁶⁷	10.66	ADRA1A CHRM3

Sources

GO Terms for Ureterolithiasis

Cellular components related to Ureterolithiasis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	dendritic spine	GO:0043197	8.96	AKAP5 APBB1
2	integral component of presynaptic membrane	GO:0099056	8.62	ADRA1A CHRM3

Biological processes related to Ureterolithiasis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	signal transduction	GO:0007165	9.56	ADRA1A AKAP5 APBB1 CHRM3
2	regulation of vasoconstriction	GO:0019229	9.16	ADRA1A CHRM3
3	positive regulation of smooth muscle contraction	GO:0045987	8.96	ADRA1A CHRM3
4	smooth muscle contraction	GO:0006939	8.62	ADRA1A CHRM3

Sources

Sources for Ureterolithiasis

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FDA Approved Drugs

²⁰ FMA

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ Genetics Home Reference

²⁷ GenomeRNAi

²⁸ GEO DataSets

²⁹ GO

³⁰ GTR

³¹ HGMD

³² HMDB

³³ HPO

³⁴ ICD10

³⁵ ICD10 via Orphanet

³⁶ ICD9CM

³⁷ IUPHAR

³⁸ KEGG

³⁹ LifeMap

⁴⁰ LncRNADisease

⁴¹ LOVD

⁴² MalaCards

⁴³ MedGen

⁴⁴ MedlinePlus

⁴⁵ MeSH

⁴⁶ MESH via Orphanet

⁴⁷ MGI

⁴⁸ miR2Disease

⁴⁹ NCBI Bookshelf

⁵⁰ NCI

⁵¹ NCIt

⁵² NDF-RT

⁵³ NIH Clinical Center

⁵⁴ NIH Rare Diseases

⁵⁵ NINDS

⁵⁶ Novoseek

⁵⁷ Novus Biologicals

⁵⁸ OMIM

⁵⁹ OMIM via Orphanet

⁶⁰ Orphanet

⁶¹ PathCards

⁶² PharmGKB

⁶³ PubMed

⁶⁴ PubMed Health

⁶⁵ QIAGEN

⁶⁶ R&D Systems

⁶⁷ Reactome

⁶⁸ Sino Biological

⁶⁹ SNOMED-CT

⁷⁰ SNOMED-CT via HPO

⁷¹ SNOMED-CT via Orphanet

⁷² TGDB

⁷³ Tocris

⁷⁴ UMLS

⁷⁵ UMLS via Orphanet

⁷⁶ UniProtKB/Swiss-Prot

⁷⁷ Wikipedia